Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $88.63 billion. The enterprise value is $113.51 billion.
Important Dates
The next estimated earnings date is Thursday, April 17, 2025, before market open.
| Earnings Date | Apr 17, 2025 |
| Ex-Dividend Date | Mar 10, 2025 |
Share Statistics
Elevance Health has 231.92 million shares outstanding. The number of shares has decreased by -1.90% in one year.
| Current Share Class | 231.92M |
| Shares Outstanding | 231.92M |
| Shares Change (YoY) | -1.90% |
| Shares Change (QoQ) | -0.86% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 91.41% |
| Float | 231.45M |
Valuation Ratios
The trailing PE ratio is 15.03 and the forward PE ratio is 11.19. Elevance Health's PEG ratio is 1.35.
| PE Ratio | 15.03 |
| Forward PE | 11.19 |
| PS Ratio | 0.51 |
| Forward PS | 0.47 |
| PB Ratio | 2.18 |
| P/TBV Ratio | 95.94 |
| P/FCF Ratio | 19.90 |
| P/OCF Ratio | 15.59 |
| PEG Ratio | 1.35 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.90, with an EV/FCF ratio of 24.94.
| EV / Earnings | 18.98 |
| EV / Sales | 0.64 |
| EV / EBITDA | 9.90 |
| EV / EBIT | 11.27 |
| EV / FCF | 24.94 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.45 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | 6.86 |
| Interest Coverage | 8.50 |
Financial Efficiency
Return on equity (ROE) is 14.77% and return on invested capital (ROIC) is 9.12%.
| Return on Equity (ROE) | 14.77% |
| Return on Assets (ROA) | 5.58% |
| Return on Invested Capital (ROIC) | 9.12% |
| Return on Capital Employed (ROCE) | 13.20% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | $57,007 |
| Employee Count | 104,200 |
| Asset Turnover | 1.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.93 billion in taxes.
| Income Tax | 1.93B |
| Effective Tax Rate | 24.46% |
Stock Price Statistics
The stock price has decreased by -23.82% in the last 52 weeks. The beta is 0.84, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -23.82% |
| 50-Day Moving Average | 385.86 |
| 200-Day Moving Average | 473.84 |
| Relative Strength Index (RSI) | 48.89 |
| Average Volume (20 Days) | 1,487,915 |
Short Selling Information
The latest short interest is 2.81 million, so 1.21% of the outstanding shares have been sold short.
| Short Interest | 2.81M |
| Short Previous Month | 3.63M |
| Short % of Shares Out | 1.21% |
| Short % of Float | 1.22% |
| Short Ratio (days to cover) | 1.58 |
Income Statement
In the last 12 months, Elevance Health had revenue of $176.81 billion and earned $5.98 billion in profits. Earnings per share was $25.68.
| Revenue | 176.81B |
| Gross Profit | 49.24B |
| Operating Income | 10.07B |
| Pretax Income | 8.59B |
| Net Income | 5.98B |
| EBITDA | 11.47B |
| EBIT | 10.07B |
| Earnings Per Share (EPS) | $25.68 |
Full Income StatementBalance Sheet
The company has $34.68 billion in cash and $31.23 billion in debt, giving a net cash position of -$22.94 billion or -$98.93 per share.
| Cash & Cash Equivalents | 34.68B |
| Total Debt | 31.23B |
| Net Cash | -22.94B |
| Net Cash Per Share | -$98.93 |
| Equity (Book Value) | 41.43B |
| Book Value Per Share | 178.78 |
| Working Capital | 18.36B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.81 billion and capital expenditures -$1.26 billion, giving a free cash flow of $4.55 billion.
| Operating Cash Flow | 5.81B |
| Capital Expenditures | -1.26B |
| Free Cash Flow | 4.55B |
| FCF Per Share | $19.63 |
Full Cash Flow StatementMargins
Gross margin is 27.85%, with operating and profit margins of 5.70% and 3.38%.
| Gross Margin | 27.85% |
| Operating Margin | 5.70% |
| Pretax Margin | 4.47% |
| Profit Margin | 3.38% |
| EBITDA Margin | 6.48% |
| EBIT Margin | 5.70% |
| FCF Margin | 2.57% |
Dividends & Yields
This stock pays an annual dividend of $6.84, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | $6.84 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | 8.73% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 26.64% |
| Buyback Yield | 1.90% |
| Shareholder Yield | 3.65% |
| Earnings Yield | 6.60% |
| FCF Yield | 5.03% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $530.83, which is 38.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $530.83 |
| Price Target Difference | 38.90% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 20.06% |
Stock ForecastsStock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |